Mangoceuticals: CEO Jacob D. Cohen received 2,000,000 shares

What happened

• Jacob D. Cohen, CEO, received a grant of 2,000,000 shares on Jul 28, 2026 at $0.00 (total $0). The Form 4 also shows gift transfers on Sep 30, 2025 (500,000 shares) and Aug 11, 2026 (2,000,000 shares), and a derivative disposition recorded on Dec 19, 2025.

Key details

• Sep 30, 2025 — Gift (G): 500,000 shares disposed at $0.00 and 500,000 shares acquired at $0.00.
• Dec 19, 2025 — Other acquisition/disposition (J): derivative disposed, amount N/A at $0.00; filing notes the Convertible Promissory Note was paid in full on Dec 19, 2025 (F5).
• Jul 28, 2026 — Grant/award (A): 2,000,000 shares acquired at $0.00 (total $0).
• Aug 11, 2026 — Gift (G): 2,000,000 shares disposed at $0.00 and 2,000,000 shares acquired at $0.00.
• Shares owned after the transactions: not stated in the provided filing.
• Relevant footnotes from the filing:
  • F1: Transfer of shares from Mr. Cohen to The Tiger Cub Trust, which Mr. Cohen controls; filing says this did not result in a change of beneficial ownership.
  • F2: Represents Mr. Cohen's direct ownership of the issuer.
  • F3: Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee; Mr. Cohen disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest.
  • F4: The 2,000,000 shares were issuable to Mr. Cohen as a bonus in lieu of a change of control payment under his employment agreement.
  • F5: On Dec 19, 2025, the Convertible Promissory Note was paid in full.
  • F6: Represents the maturity date of the Convertible Promissory Note.
• Filing timeliness: not indicated in the provided filing.

Why it may matter

• The Jul 28, 2026 entry is a grant/award at $0.00, not a market purchase.
• The Sep 30, 2025 and Aug 11, 2026 entries are gifts/transfers to a trust and the filing says those transfers did not change beneficial ownership.
• The Dec 19, 2025 entry reflects the payoff of a convertible promissory note.
• A filing does not show why the insider traded or why the company acted.